These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23262441)

  • 1. The FACT-Melanoma quality-of-life instrument: comparison of a five-point and four-point response scale using the Rasch measurement model.
    Winstanley JB; Saw R; Boyle F; Thompson J
    Melanoma Res; 2013 Feb; 23(1):61-9. PubMed ID: 23262441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methodological studies of orofacial aesthetics, orofacial function and oral health-related quality of life.
    Larsson P
    Swed Dent J Suppl; 2010; (204):11-98. PubMed ID: 20623943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The psychometric validity of the NEI VFQ-25 for use in a low-vision population.
    Marella M; Pesudovs K; Keeffe JE; O'Connor PM; Rees G; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):2878-84. PubMed ID: 20089878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Rasch and factor analysis of the Functional Assessment of Cancer Therapy-General (FACT-G).
    Smith AB; Wright P; Selby PJ; Velikova G
    Health Qual Life Outcomes; 2007 Apr; 5():19. PubMed ID: 17448239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Vision Impairment Questionnaire: an evaluation of its measurement properties using Rasch analysis.
    Lamoureux EL; Pallant JF; Pesudovs K; Hassell JB; Keeffe JE
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4732-41. PubMed ID: 17065481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of vision impairment questionnaire: an assessment of its domain structure using confirmatory factor analysis and rasch analysis.
    Lamoureux EL; Pallant JF; Pesudovs K; Rees G; Hassell JB; Keeffe JE
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1001-6. PubMed ID: 17325138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Rasch analysis to revisit the validity of the Cataract TyPE Spec instrument for measuring cataract surgery outcomes.
    Gothwal VK; Wright TA; Lamoureux EL; Pesudovs K
    J Cataract Refract Surg; 2009 Sep; 35(9):1509-17. PubMed ID: 19683146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of the Melanoma Concerns Questionnaire (MCQ-28); refinement of the EORTC QLQ-MEL38 module.
    Winstanley J; White E; Saw R; Young T; Burmeister B; Nikolic D; Busto-Cornide I; Iglesias-Pena N; Boyle F
    Psychooncology; 2020 Feb; 29(2):321-330. PubMed ID: 31652387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the Child's Challenging Behaviour Scale following evaluation using Rasch analysis.
    Bourke-Taylor HM; Pallant JF; Law M
    Child Care Health Dev; 2014 Mar; 40(2):242-9. PubMed ID: 23461777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the Rasch rating scale model to the assessment of quality of life of persons with intellectual disability.
    Gómez LE; Arias B; Verdugo MÁ; Navas P
    J Intellect Dev Disabil; 2012 Jun; 37(2):141-50. PubMed ID: 22546020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Internal construct validity of the Swiss Spinal Stenosis questionnaire: Rasch analysis of a disease-specific outcome measure for lumbar spinal stenosis.
    Comer CM; Conaghan PG; Tennant A
    Spine (Phila Pa 1976); 2011 Nov; 36(23):1969-76. PubMed ID: 21289573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health- and vision-related quality of life in intellectually disabled children.
    Cui Y; Stapleton F; Suttle C; Bundy A
    Optom Vis Sci; 2010 Jan; 87(1):37-44. PubMed ID: 19887968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the structure of Brazilian State-Trait Anxiety Inventory using a Rasch psychometric approach.
    Kaipper MB; Chachamovich E; Hidalgo MP; Torres IL; Caumo W
    J Psychosom Res; 2010 Mar; 68(3):223-33. PubMed ID: 20159207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintaining instrument quality while reducing items: application of Rasch analysis to a self-report of visual function.
    Velozo CA; Lai JS; Mallinson T; Hauselman E
    J Outcome Meas; 2000-2001; 4(3):667-80. PubMed ID: 11253902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing patient burden to the FACT-Melanoma quality-of-life questionnaire.
    Swartz RJ; Baum GP; Askew RL; Palmer JL; Ross MI; Cormier JN
    Melanoma Res; 2012 Apr; 22(2):158-63. PubMed ID: 22395418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in non-melanoma skin cancer--the skin cancer quality of life (SCQoL) questionnaire.
    Vinding GR; Christensen KB; Esmann S; Olesen AB; Jemec GB
    Dermatol Surg; 2013 Dec; 39(12):1784-93. PubMed ID: 24237851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rasch analysis of the daily living tasks dependent on vision (DLTV).
    Denny F; Marshall AH; Stevenson MR; Hart PM; Chakravarthy U
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):1976-82. PubMed ID: 17460249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refinement and reduction of the Impact of Psoriasis Questionnaire: classical test theory vs. Rasch analysis.
    Nijsten T; Unaeze J; Stern RS
    Br J Dermatol; 2006 Apr; 154(4):692-700. PubMed ID: 16536813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using the Rasch model in nursing research: an introduction and illustrative example.
    Hagquist C; Bruce M; Gustavsson JP
    Int J Nurs Stud; 2009 Mar; 46(3):380-93. PubMed ID: 19059593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maugeri Respiratory Failure questionnaire reduced form: a method for improving the questionnaire using the Rasch model.
    Vidotto G; Carone M; Jones PW; Salini S; Bertolotti G;
    Disabil Rehabil; 2007 Jul; 29(13):991-8. PubMed ID: 17612984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.